585 related articles for article (PubMed ID: 11754710)
41. Efficacy of cyclooxygenase-2-specific inhibitors.
Cannon GW; Breedveld FC
Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
[TBL] [Abstract][Full Text] [Related]
42. Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.
Collantes-Estevez E; Fernandez-Perez C
Curr Med Res Opin; 2003; 19(5):402-10. PubMed ID: 13678477
[TBL] [Abstract][Full Text] [Related]
43. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
[TBL] [Abstract][Full Text] [Related]
45. An analgesic model for assessment of acute pain response in osteoarthritis of the knee.
Moskowitz RW; Sunshine A; Hooper M; Olson NZ; Cawkwell GD
Osteoarthritis Cartilage; 2006 Nov; 14(11):1111-8. PubMed ID: 16784879
[TBL] [Abstract][Full Text] [Related]
46. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
Wolfe F; Michaud K; Burke TA; Zhao SZ
J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
[TBL] [Abstract][Full Text] [Related]
47. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.
Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
Arch Intern Med; 2000 Oct; 160(19):2998-3003. PubMed ID: 11041909
[TBL] [Abstract][Full Text] [Related]
48. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
[TBL] [Abstract][Full Text] [Related]
50. An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis.
Schnitzer TJ; Kong SX; Mitchell JH; Mavros P; Watson DJ; Pellissier JM; Straus WL
Clin Ther; 2003 Dec; 25(12):3162-72. PubMed ID: 14749154
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
52. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
[TBL] [Abstract][Full Text] [Related]
53. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
54. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Matheson AJ; Figgitt DP
Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
[TBL] [Abstract][Full Text] [Related]
55. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain.
Rømsing J; Møiniche S
Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847
[TBL] [Abstract][Full Text] [Related]
56. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
Reuben SS; Connelly NR
Anesth Analg; 2000 Nov; 91(5):1221-5. PubMed ID: 11049912
[TBL] [Abstract][Full Text] [Related]
57. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
58. Interaction of rofecoxib and celecoxib with warfarin.
Schaefer MG; Plowman BK; Morreale AP; Egan M
Am J Health Syst Pharm; 2003 Jul; 60(13):1319-23. PubMed ID: 12901032
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
[TBL] [Abstract][Full Text] [Related]
60. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
